The Range and Scientific Value of Randomized Trials.

about

No Substitute for a Doctor's Intuition.Real-World Usefulness Is Missing.Central Problem is Equipoise.

P2860

Q54511049-491F8899-E258-4A5A-AA95-C6D76E269D4F Q55228764-DCAB96C3-C51D-4E23-91D4-55E9958128A8 Q55361460-25F02B69-8572-4108-BF66-342F36AB8EDE

P2860

The Range and Scientific Value of Randomized Trials.

Item

http://www.wikidata.org/entity/Q42379773

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The Range and Scientific Value of Randomized Trials.

@en

The Range and Scientific Value of Randomized Trials.

@nl

type

Item

label

The Range and Scientific Value of Randomized Trials.

@en

The Range and Scientific Value of Randomized Trials.

@nl

prefLabel

The Range and Scientific Value of Randomized Trials.

@en

The Range and Scientific Value of Randomized Trials.

@nl

P1476

The Range and Scientific Value of Randomized Trials.

@en

P2093

Jörg Lauterberg

http://www.w3.org/2001/XMLSchema#string

Jürgen Windeler

http://www.w3.org/2001/XMLSchema#string

Stefan Lange

http://www.w3.org/2001/XMLSchema#string

P2860

Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial.

Comparison of evidence of treatment effects in randomized and nonrandomized studies.

Treatment allocation by minimisation

Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations

Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.

Effect of platelet inhibition with cangrelor during PCI on ischemic events.

What are pragmatic trials?

Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.

P304

635-640

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3238/ARZTEBL.2017.0635

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

Stefan Sauerland

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29017690

http://www.w3.org/2001/XMLSchema#string

P932

5645629

http://www.w3.org/2001/XMLSchema#string

The Range and Scientific Value of Randomized Trials.

about

P2860

P2860

The Range and Scientific Value of Randomized Trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932